0 followers
Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel second-generation immune therapies to deliver immune homeostasis based on proprietary platforms. The company has four phases 3 ready programs in Crohn’s Disease, Fibromyalgia, MS, and Pancreatic Cancer.
Michael K. Handley
Calico
6 followers
Qualigen Therapeutics
3 followers
Vera Therapeutics
2 followers
Cargo
1 follower
Capricor Therapeutics
1 follower
Edgewise Therapeutics
1 follower
Cartesian Therapeutics
1 follower
ADARx Pharmaceuticals
3 followers
Thermo Fisher Scientific
180 followers
Gilead Sciences
136 followers
Biogen
123 followers
Explore companies